Press release
Artificial Intelligence (AI) in Life Sciences Market Size is Projected to Reach US$ 15.4 Billion by 2032, Growth Rate (CAGR) of 22.4%
IMARC Group's report titled "Artificial Intelligence in Life Sciences Market Report by Offering (Software, Hardware, Services), Deployment (On-premises, Cloud-based), Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring), and Region 2024-2032". The global artificial intelligence in life sciences market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.4 Billion by 2032, exhibiting a growth rate (CAGR) of 22.4% during 2024-2032.For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artificial-intelligence-in-life-sciences-market/requestsample
Factors Affecting the Growth of Artificial Intelligence in Life Sciences Industry:
• Advancements in Drug Discovery and Development:
In the realm of drug discovery and development, AI has become a game-changer. Pharmaceutical companies and research institutions are harnessing the power of AI to streamline and accelerate this complex process. AI-driven algorithms are capable of analyzing vast datasets with unprecedented speed and precision. They can identify potential drug candidates by scanning existing scientific literature, patents, and clinical trial data. Moreover, AI can predict the efficacy and safety of these candidates, enabling researchers to prioritize the most promising ones for further study. One notable application is virtual drug screening, where AI models simulate interactions between drug compounds and biological targets. This approach dramatically reduces the time and cost traditionally associated with identifying potential drug candidates. Additionally, AI aids in optimizing clinical trial designs by identifying patient populations most likely to respond positively to a particular treatment, thus increasing the likelihood of successful drug launches.
• Personalized Medicine and Patient Care:
Personalized medicine has emerged as a transformative trend in healthcare, and AI is at its core. Healthcare providers are now equipped with AI-powered tools that analyze the comprehensive data of a patient, including genomic information, medical history, lifestyle choices, and even real-time health metrics. This wealth of information allows for the tailoring of treatment plans to individual patients. AI-driven diagnostics help healthcare professionals make quicker and more accurate diagnoses, leading to earlier interventions and improved patient outcomes. Moreover, predictive analytics can identify potential health risks and suggest preventive measures. In the field of oncology, AI assists in selecting the most effective cancer treatments based on the genetic profile of a patient, increasing the chances of successful outcomes and minimizing side effects.
• Data-Driven Research and Decision-Making:
Data is the lifeblood of the life sciences industry, and AI is instrumental in harnessing its full potential. With the exponential growth of healthcare data, traditional methods of analysis have become inadequate. AI, particularly machine learning, excels at handling and interpreting large and complex datasets. Researchers can employ AI to discover hidden patterns, relationships, and biomarkers within data, aiding in the identification of novel therapeutic targets or disease mechanisms. Additionally, AI algorithms can predict disease outbreaks by analyzing epidemiological data, helping public health officials take proactive measures. In clinical settings, AI supports evidence-based decision-making by providing real-time insights into patient conditions, enabling healthcare providers to make more informed choices regarding treatments and interventions.
Leading Companies Operating in the Global Artificial Intelligence in Life Sciences Industry:
• AiCure LLC
• Apixio Inc. (Centene Corporation)
• Atomwise Inc
• Enlitic Inc.
• International Business Machines Corporation
• Insilico Medicine Inc.
• Nuance Communications Inc.
• NuMedii Inc.
• Sensely Inc.
• Sophia Genetics SA
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-intelligence-in-life-sciences-market
Artificial Intelligence in Life Sciences Market Report Segmentation:
By Offering:
• Software
• Hardware
• Services
Software dominates the market as it encompasses a wide range of AI applications, from drug discovery algorithms and electronic health record systems to predictive analytics and personalized treatment planning tools, making it a fundamental driver of innovation and efficiency within the life sciences industry.
By Deployment:
• On-premises
• Cloud-based
Cloud-based holds maximum number of shares due to its scalability, cost-efficiency, and accessibility, making it a preferred choice for organizations seeking flexible and convenient solutions for their AI applications.
By Application:
• Drug Discovery
• Medical Diagnosis
• Biotechnology
• Clinical Trials
• Precision and Personalized Medicine
• Patient Monitoring
Drug discovery represents the largest segment due to its crucial role in revolutionizing the pharmaceutical industry, where AI-driven advancements significantly reduce development time and costs while enhancing the discovery of novel therapeutic compounds.
Regional Insights:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa
North America's dominance in the artificial intelligence in life sciences market is attributed to its robust infrastructure for research and development, significant investments in AI technology, and a well-established healthcare ecosystem that fosters the adoption of AI in the life sciences sector.
Global Artificial Intelligence in Life Sciences Market Trends:
AI is enabling the identification of new therapeutic uses for existing drugs, a process known as drug repurposing. By analyzing vast datasets on drug interactions, molecular pathways, and disease mechanisms, AI can pinpoint potential candidates for repurposing. This approach accelerates drug development and also reduces risks and costs associated with bringing new treatments to market.
Additionally, in the field of medical imaging, AI is revolutionizing diagnostics. Machine learning algorithms can analyze medical images, such as MRIs, CT scans, and X-rays, with remarkable accuracy. This assists radiologists and pathologists in detecting abnormalities, tumors, and other health issues at an earlier stage, leading to more timely interventions and improved patient outcomes.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) in Life Sciences Market Size is Projected to Reach US$ 15.4 Billion by 2032, Growth Rate (CAGR) of 22.4% here
News-ID: 3378966 • Views: …
More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India seafood…

India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025:
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.50 Billion
Market Size in 2033: USD 5.90 Billion
Market Growth Rate (CAGR) 2025-2033: 10.03%
How Big is the India Mutual Funds Industry?
The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033.
Request…

Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview:
The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…

Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay.
IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…